 Connection
Laura Dunn to Schizophrenic Psychology
This is a "connection" page, showing publications Laura Dunn has written about Schizophrenic Psychology.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.585 |
|
|
|
-
Dunn LB, Kim DS, Fellows IE, Palmer BW. Worth the risk? Relationship of incentives to risk and benefit perceptions and willingness to participate in schizophrenia research. Schizophr Bull. 2009 Jul; 35(4):730-7.
Score: 0.299
-
Roberts LW, Warner TD, Hammond KG, Dunn LB. Assessments by patients with schizophrenia and psychiatrists of relative risk of research procedures. Psychiatr Serv. 2006 Nov; 57(11):1629-35.
Score: 0.274
-
Dunn LB, Palmer BW, Appelbaum PS, Saks ER, Aarons GA, Jeste DV. Prevalence and correlates of adequate performance on a measure of abilities related to decisional capacity: differences among three standards for the MacCAT-CR in patients with schizophrenia. Schizophr Res. 2007 Jan; 89(1-3):110-8.
Score: 0.272
-
Dunn LB, Palmer BW, Keehan M, Jeste DV, Appelbaum PS. Assessment of therapeutic misconception in older schizophrenia patients with a brief instrument. Am J Psychiatry. 2006 Mar; 163(3):500-6.
Score: 0.261
-
Kaup AR, Dunn LB, Saks ER, Jeste DV, Palmer BW. Decisional capacity and consent for schizophrenia research. IRB. 2011 Jul-Aug; 33(4):1-9.
Score: 0.095
-
Jeste DV, Palmer BW, Golshan S, Eyler LT, Dunn LB, Meeks T, Glorioso D, Fellows I, Kraemer H, Appelbaum PS. Multimedia consent for research in people with schizophrenia and normal subjects: a randomized controlled trial. Schizophr Bull. 2009 Jul; 35(4):719-29.
Score: 0.075
-
Palmer BW, Dunn LB, Depp CA, Eyler LT, Jeste DV. Decisional capacity to consent to research among patients with bipolar disorder: comparison with schizophrenia patients and healthy subjects. J Clin Psychiatry. 2007 May; 68(5):689-96.
Score: 0.071
-
Palmer BW, Dunn LB, Appelbaum PS, Mudaliar S, Thal L, Henry R, Golshan S, Jeste DV. Assessment of capacity to consent to research among older persons with schizophrenia, Alzheimer disease, or diabetes mellitus: comparison of a 3-item questionnaire with a comprehensive standardized capacity instrument. Arch Gen Psychiatry. 2005 Jul; 62(7):726-33.
Score: 0.062
-
Palmer BW, Dunn LB, Appelbaum PS, Jeste DV. Correlates of treatment-related decision-making capacity among middle-aged and older patients with schizophrenia. Arch Gen Psychiatry. 2004 Mar; 61(3):230-6.
Score: 0.057
-
Jeste DV, Dunn LB, Palmer BW, Saks E, Halpain M, Cook A, Appelbaum P, Schneiderman L. A collaborative model for research on decisional capacity and informed consent in older patients with schizophrenia: bioethics unit of a geriatric psychiatry intervention research center. Psychopharmacology (Berl). 2003 Dec; 171(1):68-74.
Score: 0.054
-
Rosenheck R, Dunn L, Peszke M, Cramer J, Xu W, Thomas J, Charney D. Impact of clozapine on negative symptoms and on the deficit syndrome in refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. Am J Psychiatry. 1999 Jan; 156(1):88-93.
Score: 0.040
-
Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry. 2002 Oct; 63(10):892-909.
Score: 0.013
-
Dolder CR, Lacro JP, Dunn LB, Jeste DV. Antipsychotic medication adherence: is there a difference between typical and atypical agents? Am J Psychiatry. 2002 Jan; 159(1):103-8.
Score: 0.012
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|